Here you can see Shemesh Lab in action, on the media, as well as in different research outreach activities. Stay tuned.
Deciphering the magnetic signature of cancer
A multidisciplinary team of scientists and clinicians at the Champalimaud Centre for the Unknown developed a new noninvasive MRI methodology, called SPI (Susceptibility Perturbation MRI), that is able to identify whether lymph nodes have been infiltrated by malignant cells with high accuracy in rectal cancer patients. Such a characterisation can help define treatment strategy for rectal cancer patients and may have future implications for other malignancies.
Cutting edge imaging technology at CCU
Champalimaud Research has recently implemented cutting edge imaging technology. Find out in this interview with Dr. Noam Shemesh, head of the Neuroplasticity and Neural Activity lab, what new scientific and clinical developments this new technology will bring.